OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tyrosine Kinase Targeting
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Showing 7 citing articles:
The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
Yue Gu, Elisa Avolio, Valeria Vincenza Alvino, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Yue Gu, Elisa Avolio, Valeria Vincenza Alvino, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia
Yuichiro Iwamoto, Tomohiko Kimura, Hideyuki Iwamoto, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Yuichiro Iwamoto, Tomohiko Kimura, Hideyuki Iwamoto, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations Reveal the Mechanisms of Cinnamomum tamala in Diabetic Nephropathy Treatment: An In Silico Study
Rashmi Singh, Nilanchala Sahu, Rama Tyagi, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11868-11889
Open Access | Times Cited: 1
Rashmi Singh, Nilanchala Sahu, Rama Tyagi, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11868-11889
Open Access | Times Cited: 1
Slow progression of type 1 diabetes associated with pembrolizumab and lenvatinib combination therapy in a patient with probable slowly progressive type 1 diabetes mellitus and endometrial cancer
Iwaho Hazekawa, Norio Ishii
Diabetology International (2024)
Closed Access | Times Cited: 1
Iwaho Hazekawa, Norio Ishii
Diabetology International (2024)
Closed Access | Times Cited: 1
Development and validation of a stability‐indicating ultra‐high‐performance liquid chromatography method for the estimation of ibrutinib and trace‐level quantification of related substances using quality‐by‐design approach
Shishir Kumar Prasad, Divekar Kalpana
Biomedical Chromatography (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 2
Shishir Kumar Prasad, Divekar Kalpana
Biomedical Chromatography (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 2
Improvement of Hyperglycemia Following Treatment with Erlotinib
Arif Önder, Cihan Heybeli
Endocrine (2024)
Closed Access
Arif Önder, Cihan Heybeli
Endocrine (2024)
Closed Access
The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
Yue Gu, Elisa Avolio, Valeria Vincenza Alvino, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Yue Gu, Elisa Avolio, Valeria Vincenza Alvino, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
